TRIANA Biomedicines
Aaron Bart is a Senior Scientist at TRIANA Biomedicines, with a focus on Protein Sciences and Structural Biology since February 2022. Previously, Aaron served as an Associate Scientist and Postdoc Fellow at Merck from August 2020 to February 2022, and as a Postdoctoral Researcher and PhD Candidate at the University of Michigan from September 2014 to August 2020. The doctoral research centered on cytochrome P450 enzymes, exploring the relationship between their structure and function. Aaron has also gained experience as a Research and Early Development Intern at Genentech, where the work involved structural elucidation of multi-protein/DNA assemblies, and as an Undergraduate Research Assistant at the University of Kansas, focusing on X-ray structure determination of specific enzymes. Educational qualifications include a Doctor of Philosophy in Biophysics from the University of Michigan and a Bachelor of Science in Biochemistry from the University of Kansas.
This person is not in any offices
TRIANA Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas.